ArticleBMC cardiovascular disorders2026

The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study.

Jiali Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.